Antithrombotic therapy following heart valve replacement.
Turpie
A G
AG
Department of Medicine, McMaster University, Hamilton, Ontario, Canada. turpiea@FHS.McMaster.CA
D001705:Bioprosthesis; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006350:Heart Valve Prosthesis / Q000009:adverse effects*; D006351:Heart Valves / Q000601:surgery; D006801:Humans; D016032:Randomized Controlled Trials as Topic
D005343:Fibrinolytic Agents